AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 125 filers reported holding AUDENTES THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 2.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $13,650,000 | +517.4% | 228,100 | +189.8% | 0.01% | +400.0% |
| Q3 2019 | $2,211,000 | -1.4% | 78,700 | +5.5% | 0.00% | +100.0% |
| Q2 2018 | $2,242,000 | 0.0% | 74,600 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $2,242,000 | +34.1% | 74,600 | +39.4% | 0.00% | 0.0% |
| Q4 2017 | $1,672,000 | – | 53,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 250,620 | $9,779,000 | 11.87% |
| Versant Venture Management, LLC | 803,106 | $31,337,196,000 | 10.32% |
| GREAT POINT PARTNERS LLC | 1,572,618 | $61,364,000 | 6.07% |
| Casdin Capital, LLC | 1,010,000 | $39,410,000 | 4.33% |
| Sofinnova Investments, Inc. | 933,640 | $36,431,000 | 3.51% |
| Foresite Capital Management III, LLC | 315,331 | $12,304,000 | 3.20% |
| Redmile Group, LLC | 2,735,267 | $106,730,000 | 3.12% |
| Opaleye Management Inc. | 280,000 | $10,926,000 | 3.02% |
| Global Endowment Management, LP | 391,581 | $15,279,000 | 2.16% |
| Ghost Tree Capital, LLC | 175,000 | $6,829,000 | 1.78% |